Bryan Reiners

Bryan Reiners is Executive Vice President, Chief Insights Officer, of TerSera Therapeutics.

Previously, Bryan held a similar position at Crealta Pharmaceuticals and Actient Pharmaceuticals.

Prior to Crealta and Actient, Bryan was with Astellas Pharma, US Inc., as Director of Forecasting and Market Analytics, where he was responsible for all aspects of forecasting, business/market planning and analysis for all on-market products and products awaiting regulatory approval. 

Prior to Astellas, Bryan spent almost 17 years with Abbott in various finance, market research, and forecasting roles, including Director of Forecasting for Abbott Diabetes Care. Prior to Abbott, Bryan worked for KPMG’s audit practice in Minneapolis.

Bryan holds a BA in Accounting and Business Administration from Wartburg College in Iowa and a Master of Accountancy from St. Cloud State in Minnesota. Bryan is also a Certified Public Accountant.